Cellular Immunotherapy Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Cellular Immunotherapy Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, March 7, 2022 /EINPresswire.com/ -- Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the cellular immunotherapy market growth over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases. According to the cellular immunotherapy market forecast, these are subsequently generating higher revenues for the cellular immunotherapy market.

Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient cells as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast, and quality control production. For instance, Precision Biosciences, Inc., a biotechnology company, has created a new generation allogeneic CAR-T therapy and is conducting an ongoing trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is in collaboration with Servier, an international pharmaceutical company, and is mainly for the patients in need of advanced cancer treatment options. Additionally, in August 2020, Acepodia, a US-based next-generation cell immuno-technology company, initiated a phase 1 clinical trial for evaluating ACE1702 an allogeneic, off-the-shelf NK cell therapy for the treatment of solid tumors.

Read more on the Global Cellular Immunotherapy Market Report:
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

The global cellular immunotherapy market size is expected to grow from $3.68 billion in 2021 to $4.30 billion in 2022 at a compound annual growth rate (CAGR) of 17%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global cellular immunotherapy market share is expected to reach $7.60 billion in 2026 at a CAGR of 15.3%.

Major players covered in the global cellular immunotherapy industry are Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc. and Roche.

TBRC’s global cellular immunotherapy market report is segmented by therapy into tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, natural killer (NK) cell therapy, by primary indication into B-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, others, by application into prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumor, lung cancer, others.

Cellular Immunotherapy Global Market Report 2022 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a cellular immunotherapy market overview, forecast cellular immunotherapy market size and growth for the whole market, cellular immunotherapy market segments, geographies, cellular immunotherapy market trends, cellular immunotherapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Cellular Immunotherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:

Cell Culture Consumables And Equipment Global Market Report 2021 - By Product (Consumables, Instruments), By End User (Industrial, Biotechnology, Agriculture), By Application (Vaccination, Toxicity Testing, Cancer Research, Drug Screening And Development, Recombinant Products, Stem Cell Technology, Regenerative Medicine), By Consumables (Media, Sera, Reagents), By Instruments (Cell Culture Vessels, Bioreactors, Biosafety Cabinets, Carbon Dioxide Incubators, Centrifuges), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Cell Therapy Global Market Report 2022 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Drugs For Immunotherapy Global Market Report 2022 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors), By Therapy Area (Cancer, Autoimmune And Inflammatory Diseases, Infectious Diseases), By End User (Hospitals And Clinics, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company?

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.